http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103083342-B
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b4711b7defc1422cdb7f86d2c95657bf |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-7048 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-04 |
filingDate | 2011-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6b3100e3fa5cbddfdf0634a700ab2dad http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7759c8d96c7e326a1e281541b4c40b50 |
publicationDate | 2015-04-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | CN-103083342-B |
titleOfInvention | Application of flavan compound in preparing anti-complement medicines |
abstract | The invention belongs to the field of pharmacy, and relates to a novel application of a flavan compound in preparing anti-complement medicines. According to the invention, a modern pharmacological screening method is applied, and researches are carried out upon anti-complement active substances in plant medicines. According to the invention, the flavan compound is obtained by separation from an n-butanol extract of a commelinaceae plant commelina and an n-butanol extract of a polygonum plant fagopyrum. With an in-vitro complement activity evaluation test, it is verified that the compound has high inhibition effect upon classical pathway and alternative pathway of a complement system. The CH50 of the inhibition effect of the compound upon the classical pathway of the complement system is 0.13 +- 0.03-0.78 +- 0.06 mM, and the AP50 of the inhibition effect of the compound upon the alternative pathway of the complement system is 0.12 +- 0.01-1.00 +- 0.15 mM. The compound can be used for preparing anti-complement medicines. |
priorityDate | 2011-10-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 58.